Best Traditional Pharmaceuticals Companies in South Korea
The 73 best Traditional Pharmaceuticals companies in South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Pangen Biotech.
- HTF Market Intelligence
- Coherent Market Insights
Our analysis of 50 Traditional Pharmaceuticals companies
$3.2b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2016.
Ranked: Best Traditional Pharmaceuticals companies in South Korea
| # | Company | Disclosed funding | Employees | Founder | Tech stack | Web popularity | SEO maturity | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hanmi Pharm Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical… | — | 2,297 | — | PHPBootstrapGSAP+15 | Top 5M | rich | — | 3,367 patents Peptide hormone agonist therapeutics and combination oncology regimens | — |
| 2 | Boryung Pharmaceutical Developer of finished formulations and APIs for a wide range of disease areas | — | 1,466 | Tae Choi CEO | SentryNode.jsAnt Design+11 | Top 1M | basic | — | 14 patents Formulation technologies for solid oral dosage forms and PI3K inhibitor cancer combos | — |
| 3 | IlDong Holdings Company Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. | — | 1,451 | — | — | — | — | — | 2 patents Patents concentrated in health & consumer products | — |
| 4 | JW Pharmaceutical Developer and manufacturer of pharmaceutical products and medical devices | — | 1,218 | — | JavaNaver Mapscore-js+6 | Top 5M | basic | — | 378 patents Synthesis of heterocyclic pharmaceutical intermediates, notably finerenone and related benzimidazole derivatives. | — |
| 5 | Daewon pharm Manufacturer of pharmaceuticals and related healthcare products | — | 1,132 | — | JavaApache TomcatCloudflare+8 | Top 1M | rich | — | 25 patents Improved oral drug formulations and nuclease-resistant RNA aptamer therapeutics for viral infections | — |
| 6 | DongKook Pharma Manufacturer and distributor of pharmaceutical products | — | 1,099 | — | PHPNginxOpenResty+5 | Top 500k | rich | — | — | 2 launchs · 1 partnership |
| 7 | Handok Developer of pharmaceuticals, medical devices, and healthcare products | — | 964 | Young Jin kim CEO | JavaCloudflareUnpkg+12 | Top 5M | basic | 3 signals Contracts | 161 patents Topical/transdermal drug delivery formulations and recombinant growth hormone therapeutics, plus TRK inhibitor compounds. | — |
| 8 | Korea United Pharm Manufacturer of generic formulations | — | 885 | D Y Kang President & CEO | JavaGSAPSlick+3 | Top 5M | basic | — | 308 patents Cardiovascular combination drugs: statins with omega‑3s, cilostazol, lipophilic agents, herbal extracts. | — |
Top 6 Traditional Pharmaceuticals companies in South Korea
#1
Public · Gyeongju si, North Gyeongsang Province · founded 2010 · 76 employees$10.2Mraised▾
Pangen Biotech is a developer of biosimilars and biologics. The products developed are EPO, Factor VIII, G-CSF, and biologics. The company focuses on the development and commercialization of the products.
- Nov 2024Post IPO$10.2M
- Nov 2022Post IPO—
#2
Late Stage · Seongnam-si, Gyeonggi-do · founded 1993—raised▾
Developer of pharmaceuticals and medical devices based on regenerative medicine. The organization focuses on creating products aimed at improving human health and well-being. It utilizes proprietary technology to extract and optimize DNA for use in its products. The company exports its products to multiple countries. It also shares company updates through press releases.
#3
Public · Seoul, Seoul · founded 1976 · 177 employees—raised▾
Seoul Pharma manufactures generic oral solid products. The products are of various therapeutic categories such as respiratory, infective, CV, GI, endocrinal, anti-obesity, etc. The company also has a SmartFilm Technology to produce orally disintegrating film products.
#4
Deadpooled · Seoul, Seoul · founded 1990 · 50 employees—raised▾
Manufacturer of medicines and health foods catering to diabetic complications
#5
Public · Siheung si, Gyeonggi do · founded 2008 · 639 employees—raised▾
CDMO providing oligonucleotide, mRNA, and small molecule services. This company offers contract development and manufacturing services across various therapeutic modalities. Their services encompass research and development, encompassing virtual and global R&D capabilities. They also provide analytical testing and quality control services. The company supports clients throughout the entire drug development lifecycle, from early-stage research to commercial manufacturing.
#6
Public · Incheon, Incheon · founded 2002 · 762 employees—raised▾
Developer of antibody biosimilars. Its lead product Rensima is a biosimilar version of infliximab that is used to treat rheumatoid arthritis and other autoimmune diseases. In addition, it has other biosimilar versions of rituximab, adalimumab, bevacizumab, palivizumab, cetuximab, and etanercept in the pipeline. In 2020, the company recorded annual revenues of $1.6 B and a net profit of $433.3 M.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Traditional Pharmaceuticals coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Drug Discovery is moving in South Korea
A read on the academic research around Drug Discovery — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,026 South Korea-affiliated papers.
- Ministry of Education92
- Seoul National University79
- Yonsei University59
- Korea University54
- Korea Advanced Institute of Science and Technology50
- Computational biology5→77
- Chemical space4→43
- Virtual screening2→37
- Pharmacology2→25
- Bioinformatics2→24
- Computational biology6→83
- Virtual screening1→69
- Docking (animal)2→57
- Pharmacology4→39
- Bioinformatics1→29
- Disease1→15
- Computational biology3→13
- Pharmacology2→12
- Bioinformatics3→9
- Cancer1→4
Where drug discovery is researched across South Korea
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing drug discovery patents in South Korea
South Korea drug discovery patent filing is accelerating — 133,215 filings from 8,000 assignees (2016–2025), led by LG Chemical, Samsung, Amorepacific; annual filings 10080→13976.
- LG Chemical7571
- Samsung6868
- Amorepacific6095
- Hanmi Pharm IND3162
- LG Household & Health CARE2882
- Seoul NAT UNIV R&DB Foundation2349
- Korea INST SCI & TECH2326
- UNIV Korea RES & BUS Found2019
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.